Keyphrases
Head-and-neck Cancer
100%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
83%
Neoadjuvant
42%
Oral Tongue Squamous Cell Carcinoma (OTSCC)
29%
Tumor
28%
Phase II Trial
19%
Locally Advanced
19%
Pembrolizumab
19%
Checkpoint Blockade
19%
Neoantigen
19%
T Cells
19%
Trametinib
19%
Clinical Trials
18%
Tumor Cells
17%
Therapeutic Vaccine
16%
Immune Checkpoint Blockade
16%
Oropharyngeal Squamous Cell Carcinoma (OPSCC)
15%
Tumor Response
15%
Immune Cells
14%
Tumor-specific
13%
Anti-PD-1
11%
T Cell Infiltration
11%
Programmed Death-ligand 1 (PD-L1)
11%
HPV-related Oropharyngeal Cancer
10%
Cancer Patients
10%
Alveolar Ridge
10%
Risk Factors
10%
Window of Opportunity
10%
Survival Disparities
9%
Tobacco Use
9%
Combination Immunotherapy
9%
Novel Immunotherapy
9%
Metastasis
9%
Genome Analysis
9%
Molecular Pathways
9%
Trametinib Resistance
9%
Solid Tissue
9%
Tumor Cell Necrosis
9%
PNC-27
9%
Anticancer Peptides
9%
Novel Technique
9%
Tumorigenesis
9%
Bench to Bedside
9%
Socioeconomic Status
9%
Regret
9%
Checkpoint Immunotherapy
9%
Dental Health
9%
Yes-associated Protein 1 (YAP1)
9%
Malignancy
9%
Immunogenomics
9%
Medicine and Dentistry
Head and Neck Cancer
82%
Head and Neck Squamous Cell Carcinoma
64%
Neoplasm
55%
Biological Marker
38%
T Cell
35%
Immunotherapy
20%
Socioeconomic Status
19%
Phase II Trials
19%
Pembrolizumab
19%
Trametinib
19%
Clinical Trial
17%
Malignant Neoplasm
16%
Immune Checkpoint Blockade
16%
Oral Cavity
16%
Oropharynx Squamous Cell Carcinoma
15%
Cellular Infiltration
13%
T-Helper Cell
10%
Oral Cancer
10%
Cytotoxic T-Cell
10%
Alveolar Ridge
10%
Cancer Cell
10%
Dental Health
9%
Tobacco Use
9%
4 Iodo 2,5 Dimethoxyamphetamine
9%
Cancer
9%
Immunocompetent Cell
9%
HPV-positive Oropharyngeal Cancer
9%
Programmed Death 1 Receptor
9%
Cancer Immunization
9%
T Cell Differentiation
9%
Squamous Cell Carcinoma
9%
Major Histocompatibility Complex
9%
Cancer Model
9%
Tumor Infiltrating Lymphocyte
9%
Proteomics
9%
Immunity
9%
Hazard Ratio
8%
Immune Evasion
8%
CD8 Antigen
8%
Gene Expression
7%
Wart Virus
7%
Cancer Epidemiology
7%
Gilvetmab
7%
Epitope
6%
Formaldehyde
6%
Protein Expression
6%
Tumor Microenvironment
6%
Cohort Analysis
5%
Diseases
5%
Intercellular Adhesion Molecule 1
5%
